Pregled bibliografske jedinice broj: 1138372
HPV-16 E7 phoshorylation as a signature of malignancy
HPV-16 E7 phoshorylation as a signature of malignancy // Abstracts of the 5th Central European Forum for Microbiology, in Acta Microbiologica et Immunologica Hungarica, 64(Supplement 1)
Keszthely, Mađarska: Akadémiai Kiadó, 2017. str. 179-180 (plenarno, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1138372 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
HPV-16 E7 phoshorylation as a signature of malignancy
Autori
Tomaić, Vjekoslav
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of the 5th Central European Forum for Microbiology, in Acta Microbiologica et Immunologica Hungarica, 64(Supplement 1)
/ - : Akadémiai Kiadó, 2017, 179-180
Skup
5th Central European Forum for Microbiology
Mjesto i datum
Keszthely, Mađarska, 18.10.2017. - 20.10.2017
Vrsta sudjelovanja
Plenarno
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
HPV E7 ; phoshphorylation ; CKII
Sažetak
Among 200 Human papillomavirus (HPV) types which infect human epithelial cells only a small number of these are associated with human cancers at various anatomical sites, and they are referred as the high-risk types. Of these, cervical cancer is the most important disease which affects women predominantly in developing countries, causing more than 600, 000 cancers annually. The malignant development results from a joint action of the two main viral oncoproteins E6 and E7. They target various host proteins which are involved in the regulation of apoptosis, cell cycle control and cell polarity. E7 was shown to interact with many cellular proteins amongst which targeting of the retinoblastoma tumor suppressor (pRb) being the most relevant. Interestingly, it has been also shown that some of the other interactions were specifically modified by posttranslational modifications of E7. A good example of that is the phosphorylation of Ser31 and Ser32 by casein kinase II (CKII) which was demonstrated to play the pivotal role in modulating E7 interactions with cellular substrates. Older data have demonstrated that CKII phosphorylation plays a crucial role in E7s transformational capacity and that it is required for its interactions with TBP, while our more recent studies indicate that the upregulation in the phosphorylation of a variant of E7 leads to an increased capacity of E7 to target pRb and p130 for proteasome mediated degradation. In addition, our recent NMR analyses of CKII phosphorylated E7 reveal critical changes in the local conformation of the protein, thereby beginning to explain how phosphorylation might modulate E7 function.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Projekti:
HRZZ-IP-2016-06-2246 - Rasvjetljivanje onkogenih funkcija E6/E7 HPV-a na različitim anatomskim mjestima (HPVHNC) (Tomaić, Vjekoslav, HRZZ - 2016-06) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Vjekoslav Tomaić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE